AMBOSS raises €240 million to expand position as leading co-pilot for physicians worldwide

Berlin-based AMBOSS, a number one useful resource for medical schooling and scientific decision-making in Germany and the US, closed a €240 million financing spherical, supporting the exploration of extra worldwide markets and the growth of its providing to nurses and different well being care professionals.

The funding was led by new main buyers KIRKBI, M&G Investments and Lightrock with participation from current shareholders together with Partech.

In 2024, AMBOSS acquired Novaheal, a startup within the nursing area, and NEJM Data+, a board examination prep product for residents within the US.

“We select buyers who’re dedicated to our long-term imaginative and prescient and really versatile within the funding length. A lot of our new buyers handle evergreen funds and plan to accompany us till a attainable IPO and past,” commented Benedikt Hochkirchen, Co-founder and Co-CEO of AMBOSS. “Further funds will go into additional funding in expertise and new market segments. Selective acquisitions may even proceed to be a part of our technique.”

Based in 2012 by a group of physicians, AMBOSS is a world medical data platform altering the best way medical know-how is acquired and utilised on the level of care. With an emphasis on exact, high-quality content material, progressive AI-empowered expertise, and a user-centered method, the corporate has grown its worldwide group to over 500 staff from greater than 50 international locations, together with scientists, software program engineers, and 150+ physicians.

AMBOSS at the moment has greater than 1 million skilled customers throughout 180 international locations.

The idea is straightforward: Medical consultants distill related medical data, and AI-supported expertise locations it straight at customers’ fingertips.

In keeping with AMBOSS, medical doctors worldwide depend on them to constantly mix the newest, trusted medical content material with cutting-edge expertise. “Expertise is not going to change well being care professionals, however those that embrace it’s going to prepared the ground,” added Dr Madjid Salimi, Co-founder and Co-CEO of AMBOSS.

Key figures offered by AMBOSS:

• Each second inpatient remedy in Germany is reportedly carried out by a doctor supported by AMBOSS.
• Within the US, the “majority of medical college students” use AMBOSS to efficiently put together for exams, and rating larger than with different query banks.
• 25% of first-year US residents rely on AMBOSS to assist them present glorious affected person care.

Key to this success is robust in-house collaboration between skilled medical consultants and expertise specialists.

Offering exact and actionable suggestions on diagnostics and remedy primarily based on the newest pointers, AMBOSS is a digital co-pilot for on a regular basis scientific follow, probably saving time and avoiding remedy errors.

Peter Bason, Head of Non-public Capital at KIRKBI, says, “We’ve got adopted AMBOSS’ spectacular progress journey, from its profitable US growth to its robust give attention to innovation. Its distinctive platform is turning into an important device for each medical college students and well being care professionals, supporting studying and decision-making at each stage. We’re excited to companion with different skilled expertise and progress buyers to again AMBOSS’ visionary management group of their mission of empowering the subsequent technology of well being care professionals worldwide.”

The put up AMBOSS raises €240 million to expand position as leading co-pilot for physicians worldwide appeared first on EU-Startups.